The Patenting of Life Forms: 25 Years since the Chakrabarty Patent

Successful life science businesses depend on developing and leveraging partnerships both domestically and abroad. The foundations for these global partnerships include shared priorities placed on intellectual property. Most life science partnerships, deals and mergers pivot on U.S. intellectual property policy as well as the TRIPS Agreement. All of these foundational beliefs are not universally shared. An understanding of IP increasingly shapes industry communications with investors, patients, policy makers and other stakeholders at home and abroad.

Join BayBio and the American Association for the Advancement of Science as we explore these issues and implications for life science executives, dealmakers, communications and public affairs professionals, bioethicists, policymakers and legal professionals.